MGF
Mechano Growth Factor — a splice variant of IGF-1 released in response to mechanical stress, researched as an early-phase muscle-damage signal.
What It Is
MGF (Mechano Growth Factor) is a splice variant of IGF-1 that is released naturally in the body after intense training or injury. Its proposed role is to detect muscle damage, activate local repair cells, and initiate new tissue growth — functioning as an early “trigger” for muscle regeneration rather than a growth driver on its own.
Research interest centers on MGF’s potential to activate satellite cells (muscle stem cells), amplify the body’s natural damage-response signaling, and support localized repair at the specific muscle site where mechanical stress occurred.
Who May Benefit
- Muscle-damage and repair signaling research
- Satellite cell activation research
- Localized recovery in lagging muscle groups
- Recovery between high-intensity training sessions
- Research into the early phase of muscle regeneration (paired with later-phase IGF-1 research)
What to Expect
MGF is researched as an early-phase signaling compound — its proposed role is to activate the repair process (satellite cell activation) rather than drive growth and maturation directly, which is more associated with IGF-1 later in the repair sequence.
Because it is proposed to work best locally, research protocols often emphasize injection timing and site relative to the specific muscle group under investigation, though robust human data supporting this approach is limited.
What to Pair It With
Reconstitution
Specific reconstitution figures for this compound weren’t included in the source material. Reconstitution ratios vary by vial size and intended concentration — use a peptide reconstitution calculator and consult your research protocol source before proceeding.
Suggested Research Dosing Strategy
No specific dosing protocol was included in the source material for this compound. Any research dosing strategy should be developed with reference to current literature and a qualified research protocol source — not assumed from other compounds.
Administration Notes
No standardized administration protocol was included in the available source material.
Where MGF is discussed in research contexts, administration is generally proposed to be localized (near the specific muscle group under investigation) rather than systemic — verify this against current literature before drawing conclusions.
Research Considerations
MGF and IGF-1 are frequently discussed together as a two-phase repair sequence: MGF proposed to activate satellite cells early, with IGF-1 associated with the later growth and maturation phase.
Much of the interest in MGF is mechanistic and preclinical. Compared to BPC-157 or TB-500, there is less standardized human protocol data available, so it should be approached with a higher degree of caution and lower confidence in any specific dosing claim.
Have a specific question about MGF? Chat with Pulse, Signal IQ’s free AI research assistant — ask about mechanisms, stacking, or how it compares to other compounds.